Key result
Diaporine potentiates oxaliplatin and doxorubicin anticancer effects against liver cancer cells in vitro.
Hypothesis-generating for diaporine chemosensitization in liver cancer; in vivo studies required before clinical consideration.
In the original publication [...].
No takes yet. Share an insight, caveat, or question.
Tian et al. (2026) studied Liver cancer cells (in vitro). Diaporine combined with Oxaliplatin and Doxorubicin vs. Oxaliplatin and Doxorubicin alone was evaluated on Anticancer effects on liver cancer cells. Diaporine potentiates the anticancer effects of Oxaliplatin and Doxorubicin on liver cancer cells in vitro, but exact quantitative results were not provided.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: